Kazia Therapeutics Appoints John Friend, MD, as Chief Medical Officer
- Written by: PR Newswire Asia - News Pronto RSS
 |
SYDNEY, Nov. 16, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the appointment of John Friend, MD, as Chief Medical Officer.
In this role, Dr. Friend will be responsible for overseeing the development and commercialization of Kazia's pipeline drug...
Read more: Kazia Therapeutics Appoints John Friend, MD, as Chief Medical Officer